
Aditi Dutt
Examiner (ID: 10694, Phone: (571)272-9037 , Office: P/1649 )
| Most Active Art Unit | 1649 |
| Art Unit(s) | 1675, 1649 |
| Total Applications | 612 |
| Issued Applications | 218 |
| Pending Applications | 78 |
| Abandoned Applications | 325 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6569534
[patent_doc_number] => 20100273265
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-28
[patent_title] => 'REGENERATION AND NEOGENESIS OF RETINAL PHOTORECEPTOR CELL USING OTX2 GENE'
[patent_app_type] => utility
[patent_app_number] => 12/767164
[patent_app_country] => US
[patent_app_date] => 2010-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15884
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0273/20100273265.pdf
[firstpage_image] =>[orig_patent_app_number] => 12767164
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/767164 | Regeneration and neogenesis of retinal photoreceptor cell using Otx2 gene | Apr 25, 2010 | Issued |
Array
(
[id] => 8140617
[patent_doc_number] => 20120094858
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-04-19
[patent_title] => 'BIOMARKERS'
[patent_app_type] => utility
[patent_app_number] => 13/264638
[patent_app_country] => US
[patent_app_date] => 2010-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11773
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0094/20120094858.pdf
[firstpage_image] =>[orig_patent_app_number] => 13264638
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/264638 | BIOMARKERS | Apr 15, 2010 | Abandoned |
Array
(
[id] => 6098413
[patent_doc_number] => 20110003971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-01-06
[patent_title] => 'MODULATORS AND MODULATION OF THE INTERACTION BETWEEN RGM AND NEOGENIN'
[patent_app_type] => utility
[patent_app_number] => 12/758445
[patent_app_country] => US
[patent_app_date] => 2010-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13321
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20110003971.pdf
[firstpage_image] =>[orig_patent_app_number] => 12758445
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/758445 | MODULATORS AND MODULATION OF THE INTERACTION BETWEEN RGM AND NEOGENIN | Apr 11, 2010 | Abandoned |
Array
(
[id] => 11521931
[patent_doc_number] => 09605317
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-03-28
[patent_title] => 'Biomarkers for assessing peripheral neuropathy response to cancer treatment'
[patent_app_type] => utility
[patent_app_number] => 12/730587
[patent_app_country] => US
[patent_app_date] => 2010-03-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25737
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12730587
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/730587 | Biomarkers for assessing peripheral neuropathy response to cancer treatment | Mar 23, 2010 | Issued |
Array
(
[id] => 6495177
[patent_doc_number] => 20100286052
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'Novel use of antisecretory factor'
[patent_app_type] => utility
[patent_app_number] => 12/659142
[patent_app_country] => US
[patent_app_date] => 2010-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 11283
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20100286052.pdf
[firstpage_image] =>[orig_patent_app_number] => 12659142
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/659142 | Use of antisecretory factor | Feb 25, 2010 | Issued |
Array
(
[id] => 6494951
[patent_doc_number] => 20100286039
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-11
[patent_title] => 'Use of SCF and G-CSF in the Treatment of Cerebral Ischemia and Neurological Disorders'
[patent_app_type] => utility
[patent_app_number] => 12/714068
[patent_app_country] => US
[patent_app_date] => 2010-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16185
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20100286039.pdf
[firstpage_image] =>[orig_patent_app_number] => 12714068
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/714068 | Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders | Feb 25, 2010 | Issued |
Array
(
[id] => 6420400
[patent_doc_number] => 20100150933
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'CYTOKINE ANTAGONISTS FOR NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 12/714205
[patent_app_country] => US
[patent_app_date] => 2010-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7407
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20100150933.pdf
[firstpage_image] =>[orig_patent_app_number] => 12714205
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/714205 | CYTOKINE ANTAGONISTS FOR NEUROLOGICAL AND NEUROPSYCHIATRIC DISORDERS | Feb 25, 2010 | Abandoned |
Array
(
[id] => 6340039
[patent_doc_number] => 20100247543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 12/711938
[patent_app_country] => US
[patent_app_date] => 2010-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 21090
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20100247543.pdf
[firstpage_image] =>[orig_patent_app_number] => 12711938
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/711938 | TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES | Feb 23, 2010 | Abandoned |
Array
(
[id] => 6270485
[patent_doc_number] => 20100254952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'Isolated myeloid-like cell populations and methods of treatment therewith'
[patent_app_type] => utility
[patent_app_number] => 12/658440
[patent_app_country] => US
[patent_app_date] => 2010-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 64
[patent_figures_cnt] => 64
[patent_no_of_words] => 26976
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20100254952.pdf
[firstpage_image] =>[orig_patent_app_number] => 12658440
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/658440 | Isolated myeloid-like cell populations and methods of treatment therewith | Feb 4, 2010 | Abandoned |
Array
(
[id] => 6433552
[patent_doc_number] => 20100278800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-11-04
[patent_title] => 'Stem cell factor-like proteins and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/657731
[patent_app_country] => US
[patent_app_date] => 2010-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 35333
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0278/20100278800.pdf
[firstpage_image] =>[orig_patent_app_number] => 12657731
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/657731 | Stem cell factor-like proteins and uses thereof | Jan 24, 2010 | Abandoned |
Array
(
[id] => 7685449
[patent_doc_number] => 20100120692
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'NEUREGULINS FOR PREVENTION AND TREATMENT OF DAMAGE FROM ACUTE ASSAULT ON VASCULAR AND NEURONAL TISSUE AND AS REGULATORS OF NEURONAL STEM CELL MIGRATION'
[patent_app_type] => utility
[patent_app_number] => 12/688351
[patent_app_country] => US
[patent_app_date] => 2010-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7690
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20100120692.pdf
[firstpage_image] =>[orig_patent_app_number] => 12688351
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/688351 | Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration | Jan 14, 2010 | Issued |
Array
(
[id] => 7685450
[patent_doc_number] => 20100120691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'NEUREGULINS FOR PREVENTION AND TREATMENT OF DAMAGE FROM ACUTE ASSAULT ON VASCULAR AND NEURONAL TISSUE AND AS REGULATORS OF NEURONAL STEM CELL MIGRATION'
[patent_app_type] => utility
[patent_app_number] => 12/688287
[patent_app_country] => US
[patent_app_date] => 2010-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 7689
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20100120691.pdf
[firstpage_image] =>[orig_patent_app_number] => 12688287
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/688287 | Neuregulins for prevention and treatment of damage from acute assault on vascular and neuronal tissue and as regulators of neuronal stem cell migration | Jan 14, 2010 | Issued |
Array
(
[id] => 7732356
[patent_doc_number] => 20120015364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-01-19
[patent_title] => 'METHOD FOR THE SELECTION OF ENDOTHELIAL CELLS DEATH INDUCERS VIA NETRIN-1 AND ITS APPLICATIONS'
[patent_app_type] => utility
[patent_app_number] => 13/143804
[patent_app_country] => US
[patent_app_date] => 2010-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 8208
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0015/20120015364.pdf
[firstpage_image] =>[orig_patent_app_number] => 13143804
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/143804 | METHOD FOR THE SELECTION OF ENDOTHELIAL CELLS DEATH INDUCERS VIA NETRIN-1 AND ITS APPLICATIONS | Jan 10, 2010 | Abandoned |
Array
(
[id] => 6453815
[patent_doc_number] => 20100105608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'Peptides and methods using same for diagnosis and treatment of amyloid-associated disease'
[patent_app_type] => utility
[patent_app_number] => 12/654461
[patent_app_country] => US
[patent_app_date] => 2009-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 31925
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0105/20100105608.pdf
[firstpage_image] =>[orig_patent_app_number] => 12654461
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/654461 | Peptides and methods using same for diagnosis and treatment of amyloid-associated disease | Dec 21, 2009 | Issued |
Array
(
[id] => 6628256
[patent_doc_number] => 20100173004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'PREVENTIVE AND THERAPEUTIC VACCINE FOR ALZHEIMER\'S DISEASE'
[patent_app_type] => utility
[patent_app_number] => 12/624613
[patent_app_country] => US
[patent_app_date] => 2009-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 22872
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173004.pdf
[firstpage_image] =>[orig_patent_app_number] => 12624613
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/624613 | PREVENTIVE AND THERAPEUTIC VACCINE FOR ALZHEIMER'S DISEASE | Nov 23, 2009 | Abandoned |
Array
(
[id] => 8560304
[patent_doc_number] => 08334368
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-12-18
[patent_title] => 'Protein markers associated with bone marrow stem cell differentiation into early progenitor dendritic cells'
[patent_app_type] => utility
[patent_app_number] => 12/590989
[patent_app_country] => US
[patent_app_date] => 2009-11-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8825
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12590989
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/590989 | Protein markers associated with bone marrow stem cell differentiation into early progenitor dendritic cells | Nov 17, 2009 | Issued |
Array
(
[id] => 7776532
[patent_doc_number] => 20120039985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-02-16
[patent_title] => 'DENDRITIC CELL MODULATION IN POST-ISCHEMIC WOUNDS'
[patent_app_type] => utility
[patent_app_number] => 13/128004
[patent_app_country] => US
[patent_app_date] => 2009-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15838
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0039/20120039985.pdf
[firstpage_image] =>[orig_patent_app_number] => 13128004
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/128004 | Dendritic cell modulation in post-ischemic wounds | Nov 5, 2009 | Issued |
Array
(
[id] => 6038942
[patent_doc_number] => 20110091991
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'Protein Biomarkers for Alzheimer\'s Disease Detection'
[patent_app_type] => utility
[patent_app_number] => 12/603522
[patent_app_country] => US
[patent_app_date] => 2009-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 2594
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20110091991.pdf
[firstpage_image] =>[orig_patent_app_number] => 12603522
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/603522 | Protein Biomarkers for Alzheimer's Disease Detection | Oct 20, 2009 | Abandoned |
Array
(
[id] => 6574552
[patent_doc_number] => 20100129359
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers'
[patent_app_type] => utility
[patent_app_number] => 12/568661
[patent_app_country] => US
[patent_app_date] => 2009-10-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 24336
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20100129359.pdf
[firstpage_image] =>[orig_patent_app_number] => 12568661
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/568661 | Methods to facilitate transmission of large molecules across the blood-brain, blood-eye, and blood-nerve barriers | Oct 18, 2009 | Issued |
Array
(
[id] => 6441347
[patent_doc_number] => 20100104560
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-29
[patent_title] => 'BOTULINUM NEUROTOXIN E RECEPTORS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/569905
[patent_app_country] => US
[patent_app_date] => 2009-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 17108
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0104/20100104560.pdf
[firstpage_image] =>[orig_patent_app_number] => 12569905
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/569905 | Botulinum neurotoxin E receptors and uses thereof | Sep 29, 2009 | Issued |